PERIOPERATIVE HEMODYNAMIC CHANGES INADULT LIVING DONOR LIVER TRANSPLANTATION
成人活体肝移植围术期血流动力学变化
基本信息
- 批准号:18591409
- 负责人:
- 金额:$ 2.37万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Indocyanine green (ICG) can be used to measure cardiac output, index (CI), hepatic function, and blood volume. We used ICG to evaluate the effect of living donor liver transplantation (LDLT) for patients of end-stage liver diseases (ESLD) on perioperative hemodynamic changes and renal functions. Patient and Method: ICG examination was performed 20 adult LDLT in perioperative stage. Futhermore, examinations and were performed preoperative, immediate after LDLT (day 0), postoperative day (POD) 1, 2, 3, 7, 10, 14, 21 and 28. ICG elimination test was performed by spectrophotometric method and a noninvasive finger or nose-piece method. And renal function test including serum and urineβ2- microglobulin (BMG), fractional excretion of sodium (FENa), 24 hours creatinine clearance value(CCr), serum creatinine value(Cr), N-acetyl-β-D-glucosaminidase(NAG) value were measured at same time.Result: CI was significantly higher until POD 10 than before LDLT (4.303ア1.294 vs 3.165±0.999 1/min/m^2: P<.05) … More . After POD 14, CI was not significantly different between preLDLT and normalized(POD 14: 3.136±1.092, CI normal range 3-4 1/min/m^2). As regards renal function tests, when compare each factor by preoperative the 14th disease day, as CCr fall 75.9± 34.2 (ml/min) to 46.1±19.6. NAG shows 17.6±12.1(U/ to 14.0±11.6, it means the proximal tubule disorder. As for urine BMG shows729.9±2012.5 (μg/I) to 939.21±431.3, it means that the renal tubule and glomerulus disorder. FENa shows 1.2±1.1 (%) to 1.0±0.7, it does not show a change. Cr shows 1.2±1.1 (mg/dl) to 0.7±0.3, as for Cr, it improved.Conclusion: The characteristic of hemodynamics in ESLD patients is extremely large cardiac output, so-called hyperdynamic state. In this study, CI was significantly higher until POD 10 than before LDLT. Therefore, we think that hyperdynamic stage continue the minimum 10 days after LDLT. Although Cr value improved by LDLT, patent renal disorder existed, example for NAG and BMG value elevation. Although it was thought that the ICG test was extremely useful evaluation method for the circulation change of ESLD patient on perioperative period management, the improvement of the circulation change it doesn't necessarily mean improvement of the renal function. Therefore, we should have considered the factor except the circulation change when we thought about LDLT patient's renal function. Less
吲哚烷绿色(ICG)可用于测量心输出量,指数(CI),肝功能和血容量。我们使用ICG评估了终末期肝病(ESLD)患者对周期性血液动力学变化和肾功能的影响。患者和方法:在周期性阶段进行了20个成年LDLT检查。 FERHERMORE,检查并进行了术前进行,ICG消除测试是通过分光光度法方法和无创的手指或鼻子式方法进行的。和肾功能测试包括血清和尿液β2-微球蛋白(BMG),钠的极端洪水(FENA),24小时肌酐清除率(CCR),血清肌酐值(CR),N-乙酰基-β-D-D-葡萄糖酰胺酶(NAG)值(NAG)值在同一时间上均高于同一时间。 (4.303a1.294 vs 3.165±0.999 1/min/m^2:p <.05)…更多。 POD 14之后,PRELDLT和归一化之间的CI没有显着差异(POD 14:3.136±1.092,CI正常范围3-4 1/min/min/m^2)。关于肾功能测试,当通过术前第14疾病比较每个因素时,CCR下降75.9±34.2(ml/min)至46.1±19.6。 NAG显示17.6±12.1(U/至14.0±11.6,这意味着代理管疾病。对于尿液BMG,BMG显示了729.9±2012.5(μg/ i)至939.21±431.3,它表示肾小管和肾小球疾病。FENA和GLOMERULUS疾病。FENA。显示1.2±1.1(mg/dl)至0.7±0.3,因为CR的判断:ESLD患者的血液动力学的特征是非常大的心脏输出,所谓的高性动力学状态,CI在pod 10中都显着高。肾脏疾病的存在,例如NAG和BMG值升高。较少的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center
- DOI:10.1002/lt.20826
- 发表时间:2006-09-01
- 期刊:
- 影响因子:4.6
- 作者:Ueda, Mikiko;Oike, Fumitaka;Tanaka, Koichi
- 通讯作者:Tanaka, Koichi
生体肝移植におけるエンドトキシン吸着療法(PMX-DHP)の効果
内毒素吸附疗法(PMX-DHP)在活体肝移植中的效果
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:小崎浩一;石崎守彦 他
- 通讯作者:石崎守彦 他
Successful Treatment of Invasive Pulmonary Aspergillosis After ABO-Incompatible Living Donor Liver Transplantation Under Rapid Steroid Withdrawal Protocol
在快速类固醇撤药方案下成功治疗 ABO 不相容活体肝移植后的侵袭性肺曲霉病
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yoshimoto T;Yazumi S;Chiba T;et. al.;八隅 秀二郎;Shujiro Yazumi;八隅 秀二郎;八隅 秀二郎;Shujiro Yazumi;八隅 秀二郎;Shujiro Yazumi;貝原 聡
- 通讯作者:貝原 聡
Hepatic Artery Aneurysm after ABO Type Incompatibility Living Donor Liver Transplantation
ABO 血型不合活体肝移植后肝动脉瘤
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Hidetaka;UShigome;Kazuki;Sakai;Tomoyuki;Suzuki;Syuji;Nobori;Atsushi;Yoshizawa;Satoshi;Kaihara;Masahiko;Okamoto;Norio;Yoshimura
- 通讯作者:Yoshimura
生体肝移植における深在性真菌感染症対策
活体肝移植中深部真菌感染的防治措施
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:小崎浩一;石崎守彦 他;貝原 聡;牛込 秀隆;昇 修治;貝原 聡
- 通讯作者:貝原 聡
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHIMURA Norio其他文献
YOSHIMURA Norio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHIMURA Norio', 18)}}的其他基金
The Role of Tissue Factor (TF) In the development of Ischemic-reperfusion injury in Organ Transplantation
组织因子(TF)在器官移植缺血再灌注损伤发展中的作用
- 批准号:
12671168 - 财政年份:2000
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The development of local immunosuppression in organ transplantation
局部免疫抑制在器官移植中的进展
- 批准号:
08671378 - 财政年份:1996
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The effects of perioperative portal venous inoculation with donor lymphocytes on allograft survival in the rat.
围手术期门静脉接种供体淋巴细胞对大鼠同种异体移植物存活的影响。
- 批准号:
03670594 - 财政年份:1991
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Assessing Multi-level Barriers to Racial Equity in Living Liver Donor Transplantation
评估活体肝脏捐赠者移植中种族平等的多层次障碍
- 批准号:
10730834 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
A Novel Human Virus in Patients with Cryptogenic Liver Disease
隐源性肝病患者中的一种新型人类病毒
- 批准号:
10636331 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
The Impact of Frailty on Liver Transplant Outcomes in Older Adults with Hepatocellular Carcinoma
虚弱对老年肝细胞癌肝移植结果的影响
- 批准号:
10570786 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Development of Machine Learning Composite Measures for Graft Outcome Selection in Pediatric Liver Transplantation
开发用于小儿肝移植移植结果选择的机器学习综合措施
- 批准号:
10484107 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别:
Patient Oriented Research in Solid Organ Transplantation
以患者为中心的实体器官移植研究
- 批准号:
10582518 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别: